Capture China new ivf boom
ZHENGHE INSIGHTS
Why art service are high demand in China
Driven by demographic, policy, and socioeconomic shifts, China's burgeoning assisted reproductive technology (ART) market is undergoing an unprecedented expansion, with the IVF sector alone projected to grow from US5.77 billion in 2024 to US11.26 billion by 2033 at a 7.72% CAGR.
While domestic capacity is expanding, a significant and persistent gap between soaring demand and available services creates a substantial opportunity for international providers. Regulatory Arbitrage is one of the most important factors.
Key services that are either banned or heavily restricted domestically create a high-value, non-competitive niche for overseas clinics —>
· Egg freezing for unmarried women
· Surrogacy & Gender Selection
· Gamete Donation
About China international conference on assisted reproduction
Zhenghe Exhibition Group has successfully organized the International Conference on Assisted Reproduction, establishing a premier platform for the industry in China.
Backed by a mature and professional team with deep market expertise, we do more than just host events—we empower your business growth by seamlessly connecting you with a robust network of verified professional channels and partners."
since 2015
Upcoming
events
Explore our calendar
Hangzhou
3-4, September, 2026
Beijing
19-21, November, 2026
Shanghai
23-25, April, 2026
shenzhen
16-18, July, 2026